Insulet
$193.51
59
-$1.52-0.78% Friday 20:00
統計
當日最高
196.94
當日最低
191.94
52週最高
223.56
52週最低
125.82
成交量
510,272
平均成交量
791,601
市值
13.57B
市盈率
36.93
股息收益率
-
股息
-
即將到來
收益
31Oct確認
預期每股收益
0.75838
實際每股收益
N/A
人們還關注
此列表基於在 Stock Events 上關注 PODD 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
Tandem Diabetes Care
TNDM
市值2.45B
Medtronic
MDT
市值105.2B
Dexcom
DXCM
市值27.95B
Abbott Laboratories
ABT
市值189.14B
Insulet
PODD
市值12.76B
Senseonics
SENS
市值202.18M
Novo Nordisk
NVO
市值452.48B
Sanofi
SNY
市值132.87B
Mannkind
MNKD
市值1.39B
分析師評級
229$平均價格目標
最高估價為 $260。
來自過去 6 個月內的 11 個評級。這不是投資建議。
買入
73%
持有
27%
賣出
0%
關於
Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Show more...
首席執行官
Shacey Petrovic
員工
3000
國家
US
ISIN
US45784P1012
WKN
000A0MQX8